We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates All In One Hematology Solution Designed for Enhanced Testing Efficiency

By LabMedica International staff writers
Posted on 21 May 2023

Mindray (Shenzhen, China) is demonstrating its latest technologies and solutions in in-vitro diagnostics at WorldLab–EuroMedLab Roma 2023, including the company’s ALL IN ONE hematology solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. More...

Mindray's ALL IN ONE Hematology Solution enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, SAA, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and high demand for turnaround times. Mindray's ALL IN ONE Hematology Solution comprises the H50 HPLC analyzer for HbA1c analysis, MC-80 digital morphology analyzer for slide reading, SC-120 auto slide maker & stainer for smear preparation, BP-200n ESR & SAA analyzer for ESR + SAA analysis, BC-6800Plus auto hematology analyzer for accurate & reliable analysis by 3D SF-Cube with auto re-analysis, and TM-1000 tube sorter for sorting & storage.

Among other innovative products being showcased at Mindray’s booth is the CAL 8000 New Generation Cellular Analysis Line which marks Mindray's expertise and innovative power in the hematology area for large-scale laboratories. It has higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray’s new MC-80 Digital Cell Morphology Analyzer, the CAL 8000 takes hematology analysis automation to the next level.

Also featuring at the event is Mindray’s M1000 integrated chemistry and immunoassay system which is specially designed for large-scale laboratories. It supports loading up to 580 samples continuously at one time and automatic sample tube decapping. The M1000 comes with innovative technologies, such as 360-degree sample barcode scanning, PDR optical platform, HIL.L SI solution, timely environment pressure, and CO2 monitoring, VU-Mix and FS-sampling, and whole blood HbA1c with auto sample increment tests. All these technologies help deliver high working efficiency and deliver high-quality patient reports in a short turn-around time (TAT).

Related Links:
Mindray 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: PhD researcher Olivia Moscatelli and Associate Professor Jason Tye-Din with the highly sensitive technology used to detect the critical IL-2 signal (Photo courtesy of WEHI)

Groundbreaking Blood Test Detects Celiac Disease in Patients Without Gluten Exposure

Getting a reliable diagnosis for coeliac disease has long required patients to endure weeks of consuming gluten—a painful process for many already following gluten-free diets. Now, a groundbreaking blood... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The LIAISON PLEX® Gram-Positive Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection

Each year, around 250,000 individuals in the US are diagnosed with bloodstream infections (BSIs). Sepsis caused by these infections carries a mortality rate ranging from 16% to 40%, and any delay in administering... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.